<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#336fb7"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007b83"/>
	<fontspec id="font2" size="9" family="Courier" color="#007b83"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#231f20"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t2" reading_order_no="54" segment_no="24" tag_type="text">Page 1 of 8<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="55" segment_no="25" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="155" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">CytoJournal</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="50" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research<b>CytoJournal</b></text>
<text top="105" left="55" width="490" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Immunohistochemical detection of hTERT in urothelial lesions: a<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="123" left="55" width="258" height="15" font="font9" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="title">potential adjunct to urine cytology</text>
<text top="140" left="55" width="256" height="14" font="font10" id="p1_t9" reading_order_no="6" segment_no="5" tag_type="text">Walid Khalbuss 1 and Steve Goodison* 2<b>Immunohistochemical detection of hTERT in urothelial lesions: a </b></text>
<text top="175" left="55" width="480" height="9" font="font12" id="p1_t10" reading_order_no="7" segment_no="6" tag_type="text">Address: 1 Dept. of Pathology, University of Florida, Jacksonville, FL, USA and 2 Dept. of Surgery, University of Florida, Jacksonville, FL, USA<b>potential adjunct to urine cytology</b></text>
<text top="190" left="55" width="327" height="8" font="font12" id="p1_t11" reading_order_no="8" segment_no="7" tag_type="text">Email: Walid Khalbuss - khalbuss@yahoo.com; Steve Goodison* - steve.goodison@jax.ufl.edu</text>
<text top="202" left="55" width="92" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="350" left="112" width="44" height="10" font="font14" id="p1_t13" reading_order_no="19" segment_no="16" tag_type="title">Abstract</text>
<text top="365" left="112" width="385" height="9" font="font15" id="p1_t14" reading_order_no="20" segment_no="17" tag_type="text">Background: Urine cytology has a critical role in evaluation for bladder carcinoma. Due to the</text>
<text top="376" left="112" width="386" height="9" font="font16" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">low sensitivity of this technique, ancillary modalities such as the detection of markers of malignancy</text>
<text top="388" left="112" width="386" height="9" font="font16" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">by immunochemistry are desirable. Promising factors in this context are components of the human</text>
<text top="400" left="112" width="386" height="9" font="font16" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">telomerase enzyme complex. Telomerase repairs and extend telomeres, which when eroded</text>
<text top="412" left="112" width="386" height="9" font="font16" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">beyond a critical limit trigger a senescence checkpoint. Accordingly, while absent in normal somatic</text>
<text top="423" left="112" width="385" height="9" font="font16" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">cells, telomerase activity has been detected in the great majority of malignant tumor specimens</text>
<text top="435" left="112" width="362" height="9" font="font16" id="p1_t20" reading_order_no="26" segment_no="17" tag_type="text">tested, and so has potential value for the recognition of malignant cells in clinical specimens.</text>
<text top="452" left="112" width="385" height="9" font="font15" id="p1_t21" reading_order_no="27" segment_no="18" tag_type="text">Methods: In this study, we investigated whether the immunohistochemical detection of the<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16901344">  </a></text>
<text top="464" left="112" width="386" height="9" font="font16" id="p1_t22" reading_order_no="28" segment_no="18" tag_type="text">catalytic subunit of telomerase (hTERT) can aid cytology in the diagnosis of bladder lesions. Findings<b>Abstract</b></text>
<text top="475" left="112" width="386" height="9" font="font16" id="p1_t23" reading_order_no="29" segment_no="18" tag_type="text">from the retrospective evaluation of over 100 cell blocks, including urine sediments from confirmed<b>Background: </b></text>
<text top="487" left="112" width="325" height="9" font="font16" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">malignant and benign conditions, were compared with routine urine cytology data.</text>
<text top="504" left="112" width="385" height="9" font="font15" id="p1_t25" reading_order_no="31" segment_no="19" tag_type="text">Results: The presence of hTERT protein was indicative of the transformation of urothelia to a</text>
<text top="516" left="112" width="386" height="9" font="font16" id="p1_t26" reading_order_no="32" segment_no="19" tag_type="text">malignant phenotype. Nucleolar hTERT was expressed in 27 (93%) of 29 samples obtained from</text>
<text top="527" left="112" width="386" height="9" font="font16" id="p1_t27" reading_order_no="33" segment_no="19" tag_type="text">patients with confirmed primary bladder cancer. Conversely, hTERT was detectable in only 3</text>
<text top="539" left="112" width="386" height="9" font="font16" id="p1_t28" reading_order_no="34" segment_no="19" tag_type="text">(0.8%) of 39 samples from benign conditions. The hTERT assay showed higher diagnostic sensitivity</text>
<text top="551" left="112" width="386" height="9" font="font16" id="p1_t29" reading_order_no="35" segment_no="19" tag_type="text">(84.8%) than published urine cytology data (~65%) for confirmed bladder carcinoma, however, the</text>
<text top="563" left="112" width="293" height="9" font="font16" id="p1_t30" reading_order_no="36" segment_no="19" tag_type="text">hTERT assay was less specific than cytology (65.2% vs. ~95% respectively).</text>
<text top="579" left="112" width="385" height="9" font="font15" id="p1_t31" reading_order_no="37" segment_no="20" tag_type="text">Conclusion: As a highly sensitive marker, immunohistochemical hTERT detection in urine<b>Methods: </b></text>
<text top="591" left="112" width="385" height="9" font="font16" id="p1_t32" reading_order_no="38" segment_no="20" tag_type="text">sediments represents a reliable adjunct to cytology in the accurate diagnosis of urothelial</text>
<text top="603" left="112" width="43" height="9" font="font16" id="p1_t33" reading_order_no="39" segment_no="20" tag_type="text">neoplasms.</text>
<text top="652" left="55" width="60" height="10" font="font14" id="p1_t34" reading_order_no="40" segment_no="21" tag_type="title">Background</text>
<text top="664" left="55" width="241" height="9" font="font17" id="p1_t35" reading_order_no="41" segment_no="23" tag_type="text">The diagnosis of suspicious bladder lesions is, in part,</text>
<text top="676" left="55" width="241" height="9" font="font17" id="p1_t36" reading_order_no="42" segment_no="23" tag_type="text">dependent on the demonstration of atypical cells in the<b>Results: </b></text>
<text top="687" left="55" width="241" height="9" font="font17" id="p1_t37" reading_order_no="43" segment_no="23" tag_type="text">cytological examination of voided urine or bladder wash-</text>
<text top="699" left="55" width="241" height="9" font="font17" id="p1_t38" reading_order_no="44" segment_no="23" tag_type="text">ings. However, the relatively low diagnostic sensitivity of</text>
<text top="711" left="55" width="241" height="9" font="font17" id="p1_t39" reading_order_no="45" segment_no="23" tag_type="text">urinary cytology warrants the development of improved</text>
<text top="722" left="55" width="241" height="9" font="font17" id="p1_t40" reading_order_no="46" segment_no="23" tag_type="text">non-invasive diagnostic techniques [1]. Furthermore, one</text>
<text top="652" left="313" width="241" height="9" font="font17" id="p1_t41" reading_order_no="47" segment_no="22" tag_type="text">of the major problems in daily cytology practice is to dis-</text>
<text top="664" left="313" width="241" height="9" font="font17" id="p1_t42" reading_order_no="48" segment_no="22" tag_type="text">tinguish benign/reactive cells from malignant cells. Addi-</text>
<text top="676" left="313" width="241" height="9" font="font17" id="p1_t43" reading_order_no="49" segment_no="22" tag_type="text">tional techniques, such as immunocytochemistry and<b>Conclusion: </b></text>
<text top="687" left="313" width="241" height="9" font="font17" id="p1_t44" reading_order_no="50" segment_no="22" tag_type="text">flow cytometry, may provide significant help in this differ-</text>
<text top="699" left="313" width="241" height="9" font="font17" id="p1_t45" reading_order_no="51" segment_no="22" tag_type="text">ential diagnosis. A number of antibodies directed against</text>
<text top="711" left="313" width="241" height="9" font="font17" id="p1_t46" reading_order_no="52" segment_no="22" tag_type="text">specific cell type antigens have been used in urine cytol-</text>
<text top="722" left="313" width="241" height="9" font="font17" id="p1_t47" reading_order_no="53" segment_no="22" tag_type="text">ogy to enhance the cytological diagnosis, including<b>Background</b></text>
<text top="244" left="55" width="85" height="7" font="font18" id="p1_t48" reading_order_no="10" segment_no="9" tag_type="text">Published: 10 August 2006</text>
<text top="259" left="55" width="71" height="7" font="font19" id="p1_t49" reading_order_no="11" segment_no="12" tag_type="text">CytoJournal 2006, 3 :18</text>
<text top="259" left="134" width="92" height="7" font="font18" id="p1_t50" reading_order_no="12" segment_no="12" tag_type="text">doi:10.1186/1742-6413-3-18</text>
<text top="244" left="310" width="78" height="7" font="font18" id="p1_t51" reading_order_no="17" segment_no="10" tag_type="text">Received: 25 April 2006</text>
<text top="254" left="310" width="86" height="7" font="font18" id="p1_t52" reading_order_no="18" segment_no="11" tag_type="text">Accepted: 10 August 2006</text>
<text top="273" left="55" width="235" height="7" font="font18" id="p1_t53" reading_order_no="13" segment_no="13" tag_type="text">This article is available from: http://www.cytojournal.com/content/3/1/18<a href="">1</a>]. Furthermore, one</text>
<text top="287" left="55" width="201" height="7" font="font18" id="p1_t54" reading_order_no="14" segment_no="14" tag_type="text">© 2006 Khalbuss and Goodison; licensee BioMed Central Ltd.</text>
<text top="297" left="55" width="492" height="7" font="font18" id="p1_t55" reading_order_no="15" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="306" left="55" width="400" height="7" font="font18" id="p1_t56" reading_order_no="16" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
